Y-Intercept (HK)’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,466
Closed -$428K – 1776
2026
Q2
$428K Buy
+5,466
New +$373K 0.01% 1358
2026
Q1
– Sell
-45,549
Closed -$3.07M – 1755
2025
Q4
$3.07M Buy
45,549
+28,648
+170% +$1.93M 0.07% 417
2025
Q3
$1.24M Sell
16,901
-77,700
-82% -$5.16M 0.03% 872
2025
Q2
$4.92M Buy
+94,601
New +$5.38M 0.12% 224
2024
Q2
– Sell
-24,900
Closed -$1.01M – 1590
2024
Q1
$1.01M Buy
24,900
+3,127
+14% +$117K 0.08% 384
2023
Q4
$805K Sell
21,773
-13,401
-38% -$505K 0.07% 401
2023
Q3
$1.34M Buy
+35,174
New +$1.44M 0.13% 229
2023
Q2
– Sell
-13,501
Closed -$516K – 1452
2023
Q1
$516K Buy
+13,501
New +$633K 0.06% 517

Other funds holding HALO

Y-Intercept (HK)'s HALO Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Halozyme (HALO) in Q3 2026, closing a stake of 5,466 shares — an estimated $428K sold.

Y-Intercept (HK) first reported a position in HALO in Q1 2023 and held it in 8 quarters. The position peaked at $4.92M in Q2 2025. 172 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Y-Intercept (HK) reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 5,466 Halozyme shares in Q3 2026, an estimated $428K.
  • Y-Intercept (HK) first reported a position in Halozyme in Q1 2023 and held it in 8 quarters.
  • Y-Intercept (HK)'s Halozyme position peaked at $4.92M in Q2 2025.
  • 172 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.